News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Acknowledging Diversity Empowers Solutions for Society’s Pressing Problems

two men standing next a woman in an auditorium

Diversity is a tool for truth, not political agendas, said Vincent D. Rougeau,  president of the College of the Holy Cross, in his keynote address April 7 for Weill Cornell Medicine’s seventh annual Diversity Week. 

Rougeau delivered the Elizabeth A. Wilson-Anstey, EdD Lecture, “Why Commitment to Diversity Still Matters,” in Uris Auditorium as part of the annual celebration of Weill Cornell Medicine’s commitment to greater equity, diversity and inclusion in academic medicine and health care.    

“We’re living in a moment in which it feels rather fraught to acknowledge the things that we know are true,” said Rougeau, a lawyer who in 2021 became the first Black president of Holy Cross, the nation’s only undergraduate Jesuit liberal arts college. “I see diversity as a reality check. It’s engaging the world as it is. Acknowledging its importance allows us to solve real problems.”

In his deeply personal speech, Rougeau drew from his family’s civil rights history and experience as a legal scholar to reinforce the concept that diversity is about understanding people, not just representation. Indeed, diversity is essential for effective health care, education and leadership, he said, because it ensures we understand and care for people as they truly are, not as abstractions.

When Protective Lipids Decline, Health Risks Increase

Di Lorenzo Ceremides


New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression. The study, published Feb. 25 in Nature Communications, challenges the conventional belief that a type of fat called ceramides accumulates in blood vessels causing inflammation and health risks. Instead, their preclinical findings reveal that when ceramides decrease in endothelial cells lining blood vessels, it can be damaging and cause chronic illnesses. Ironically, the findings could ultimately lead to therapies that maintain high levels of these protective lipids in patients with obesity.

Dr. Annarita Di Lorenzo

Weill Cornell Medicine Researcher Wins the SPARK NS 2025 Immersive Translational Research Grant

Man standing in a laboratory

Dr. Timothy Ryan, the Tri-Institutional Professor of Biochemistry at Weill Cornell Medicine, has been named one of eight academic principal investigators to participate in the SPARK NS Translational Research Program, 2025 cohort.

The two-year program is designed to advance promising academic discoveries in neuroscience by providing up to $2 million in funding, education, mentoring and networking opportunities.